Incyte
INCY
$56.86
Share price
-0.33%
Change (1 day)
-14.11%
Change (1 year)
Categories
Incyte (INCY) - Net assets
Net assets on the balance sheet as of March 2024 : $5.39 B
According to Incyte's latest financial reports the company has $5.39 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Incyte - Net assets on balance sheet (from 2001 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $5.18 B | 18.76% |
| 2022-12-31 | $4.37 B | 15.92% |
| 2021-12-31 | $3.77 B | 44.37% |
| 2020-12-31 | $2.61 B | 0.49% |
| 2019-12-31 | $2.59 B | 34.91% |
| 2018-12-31 | $1.92 B | 18.11% |
| 2017-12-31 | $1.63 B | 288.74% |
| 2016-12-31 | $0.41 B | 145.08% |
| 2015-12-31 | $0.17 B | -309.68% |
| 2014-12-31 | $-81.63 M | -57.73% |
| 2013-12-31 | $-0.2 B | 10.37% |
| 2012-12-31 | $-0.18 B | -22.95% |
| 2011-12-31 | $-0.23 B | 156.17% |
| 2010-12-31 | $-88.65 M | -13.42% |
| 2009-12-31 | $-0.11 B | -53.62% |
| 2008-12-31 | $-0.23 B | 38.39% |
| 2007-12-31 | $-0.16 B | 87.87% |
| 2006-12-31 | $-84.91 M | 337.74% |
| 2005-12-31 | $-19.4 M | -124.7% |
| 2004-12-31 | $78.51 M | -49.12% |
| 2003-12-31 | $0.15 B | -48.97% |
| 2002-12-31 | $0.30 B | -31.3% |
| 2001-12-31 | $0.44 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $39.75 B | 637.00% | 🇨🇭 Switzerland |
 Pfizer PFE | $89.28 B | 1,555.24% | 🇺🇸 USA |
 Eli Lilly LLY | $12.89 B | 139.09% | 🇺🇸 USA |
 Amgen AMGN | $6.23 B | 15.53% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.70 B | -87.01% | 🇺🇸 USA |
 Geron GERN | $0.24 B | -95.40% | 🇺🇸 USA |
 CTI BioPharma
CTIC | -$25.35 M | -100.47% | 🇺🇸 USA |
 AVEO Oncology
AVEO | $28.84 M | -99.47% | 🇺🇸 USA |
 Ardelyx ARDX | $0.16 B | -96.91% | 🇺🇸 USA |